Using a glowing SARS-CoV-2 virus and mice to explain how antibodies protect from infection and severe disease

An international multisite research collaboration, including CITF-funded researcher Dr. Andrés Finzi from the Université de Montréal, used genetically modified mice that mimic COVID-19 disease in humans to study how antibodies from people who have recovered from COVID-19 could prevent severe disease in other people. The authors concluded that these antibodies were effective in not … Continue reading Using a glowing SARS-CoV-2 virus and mice to explain how antibodies protect from infection and severe disease